Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimising Patient Safety During the Use of Intraoperative Imaging for the Surgical Management of Facial Fractures: A Pilot Study.

Craniomaxillofacial trauma & reconstruction·2026
Same author

SIMPL Study of Surgical Feedback: Faculty Identity Outweighs Trainee Factors in Narrative Assessments.

Journal of surgical education·2026
Same author

Meta-Analysis of Genetic Variants Associated With HBV Infection Susceptibility and Hepatocellular Carcinoma Risk.

Journal of viral hepatitis·2026
Same author

Analysis of Participation Patterns and Injury-Triggering Factors in Elderly Grassroots Sports Using Association Rule Mining.

Life (Basel, Switzerland)·2026
Same author

Glycine receptors in circulating white blood cells regulated by neuroinflammation.

Frontiers in immunology·2026
Same author

Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing Cancers.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025

Related Experiment Video

Updated: Sep 20, 2025

Author Spotlight: Efficient CRISPR/Cas9 Genome Editing in Bone Marrow-Derived Macrophages for Precise Gene Disruption
04:51

Author Spotlight: Efficient CRISPR/Cas9 Genome Editing in Bone Marrow-Derived Macrophages for Precise Gene Disruption

Published on: August 4, 2023

1.8K

Engineering Human Circulating Monocytes/Macrophages by Systemic Deliverable Gene Editing.

So Yoon Lee1, Javier Fierro1, Jake Dipasquale1

  • 1Department of Molecular and Translational Medicine of Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center at El Paso, El Paso, TX, United States.

Frontiers in Immunology
|June 6, 2022
PubMed
Summary
This summary is machine-generated.

We developed novel nanoparticles to deliver plasmid DNA for macrophage gene editing. This breakthrough enables effective gene delivery into macrophages, offering a new therapeutic approach for various diseases.

Keywords:
IL-4human circulating monocytes-derived macrophagesimmune regulationplasmid DNAsystemic deliverable gene-editing

More Related Videos

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells
11:16

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

7.8K
CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

3.7K

Related Experiment Videos

Last Updated: Sep 20, 2025

Author Spotlight: Efficient CRISPR/Cas9 Genome Editing in Bone Marrow-Derived Macrophages for Precise Gene Disruption
04:51

Author Spotlight: Efficient CRISPR/Cas9 Genome Editing in Bone Marrow-Derived Macrophages for Precise Gene Disruption

Published on: August 4, 2023

1.8K
Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells
11:16

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

7.8K
CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

3.7K

Area of Science:

  • Biomedical Engineering
  • Cell Biology
  • Gene Therapy

Background:

  • Macrophage genetic engineering is crucial for treating diseases like cancer and infections.
  • Plasmid DNA (pDNA) delivery into terminally differentiated macrophages is challenging due to nuclear membrane barriers.

Purpose of the Study:

  • To develop an effective method for delivering plasmid DNA into macrophages for genetic engineering.
  • To engineer macrophages using a novel nanoparticle (NP) system for enhanced gene delivery.

Main Methods:

  • Developed core-shell nanoparticles (NPs) using a novel cationic lipid to encapsulate IL-4 pDNA (IL-4pDNA-NPs).
  • Transfected human blood monocyte-derived macrophages (MDM) with IL-4pDNA-NPs.
  • Assessed NP internalization, nuclear delivery, exogenous IL-4 expression, and M2 macrophage polarization in vitro and in vivo.

Main Results:

  • IL-4pDNA-NPs were efficiently internalized by MDM and delivered to the nucleus within 2 hours.
  • Exogenous IL-4 expression was detected within 1-2 days and persisted for up to 30 days.
  • Functional IL-4 expression induced M2 macrophage polarization in vitro and in a mouse model of inflammation.

Conclusions:

  • The developed NPs protect pDNA from degradation and facilitate nuclear transport, enhancing gene delivery in macrophages.
  • This nanoparticle-mediated gene delivery system offers a promising strategy for macrophage-based gene therapy.
  • The approach provides a new solution for gene editing in monocytes and macrophages for therapeutic applications.